(Q34352552)

1 August 2017

0 references

1 reference

title

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis (English)

1 reference

1 August 2017

0 references

0 references

0 references

0 references

Tondo L

1

1 reference

1 August 2017

Hennen J

series ordinal

2

1 reference

1 August 2017

Baldessarini RJ

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Acta Psychiatrica Scandinavica

1 August 2017

published in

1 reference

1 August 2017

volume

104

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

163-172

1 reference

Sixteen-year mortality in patients with affective disorder commenced on lithium

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

A plea for integrity of the bipolar disorder concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Inadequate treatment for major depression both before and after attempted suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Prevention of suicide: aspirations and evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Antidepressant drugs and the emergence of suicidal tendencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Trends and availability of suicide methods in Finland. Proposals for restrictive measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Mortality of a lithium-treated population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Discontinuing antidepressant treatment in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Release of 3H-dopamine and analogous monoamines from rat striatal tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

Long-term outcome and mortality of treated versus untreated bipolar and depressed patients: A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Suicide and Primary Affective Disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

The epidemiology of suicide and parasuicide.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Effect of lithium maintenance on suicidal behavior in major mood disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Lithium prophylaxis in recurrent affective illness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Treatment experiences in the lithium clinic at St Thomas Hospital

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Outcome of bipolar disorder on long-term treatment with lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Five-year mortality in lithium-treated manic-depressive patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Mortality in affective disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Suicide mortality in patients on lithium maintenance therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Lithium treatment and risk of suicidal behavior in bipolar disorder patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Effects of the Rate of Discontinuing Lithium Maintenance Treatment in Bipolar Disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Effects of acute tryptophan depletion in lithium-remitted manic patients: a pilot study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00464.X

7 January 2021

10.1034/J.1600-0447.2001.00464.X

Identifiers

DOI

1 reference

1 August 2017

1 reference